Lonza to manufacture Intellect Neurosciences drug; Scammers go after Internet drug buyers;

> India has put new price controls on nearly 350 drugs, up from the 74 that had limits. Story

> Drugmakers are now owed between $15.4 billion and $19.5 billion by European countries that have yet to pay their pharma bills. Story

> Intellect Neurosciences plans to have Lonza manufacture its new antibody-drug conjugate Conjumab-A. Item

> Indian API maker Cadila Pharmaceutical says one of its employees working with its pharmaceutical division has been arrested for embezzlement. Story

> While the diabetes drug metformin holds potential as a cheap and effective treatment against some cancers, drugmakers are reluctant to invest in research for a drug already off patent. Story

And Finally... The FDA is investigating reports that scammers are calling people who have purchased drugs from Internet pharmacies and threatening them if they don't pay fines. Story

Suggested Articles

Recipharm has been building its capabilities in sterile injectable and inhalation drugs. Now it is buying a CDMO that manufactures devices for both.

The FDA has slapped the parent of Dollar Tree stores with a warning letter saying some CMOs that made its OTC products were among the world's worst.

GSK expects Shingrix supplies to rise slightly in 2020, but the real "step change" will come in 2024 with a brand-new manufacturing facility.